Exploring the benefits of CGM in type 2 diabetes SPONSORED: An expanding evidence-base is creating a compelling rationale for increased use of continuous glucose monitoring.
Aboriginal-led study sees 30% achieve diabetes remission A first-of-its-kind study in Australia has highlighted the importance of community-led initiatives in diabetes management.
In Practice: New MBS item for continuous nerve blockade The item will be added on 1 March to support the provision of continuous nerve blockade using a catheter technique.
RACGP calls for GP permission to provide diabetes technology access As part of a consultation process for subsidised access to continuous glucose monitoring, the college says GPs are ‘essential’ to supporting equitable access.
GPs can now approve glucose monitors for DVA card holders Access to the technology should significantly improve quality of life for veterans with diabetes, but patients without DVA cards still face barriers.
GPs key for equitable access to glucose monitors: RACGP An ongoing NDSS review has sparked renewed calls to allow GPs to certify patients with diabetes for access to subsidised continuous glucose monitors.
‘Super-spreader’ areas identified in health settings: Study Researchers say low-cost CO2 monitors have an important role to play in identifying the interventions needed to mitigate spread of airborne viruses.
‘Nonsensical’ to stop GPs approving access to glucose monitors The decision to block GPs from certifying patient access to the devices ‘needs to be reviewed and rectified,’ the RACGP president says.
Diabetes risk could be 28% higher after COVID infection A study has noted increased type 2 diabetes incidence in people recovering from COVID, signalling the need for ongoing monitoring.
Intermediate hyperglycaemia nearly doubles risk of major CV event And research suggests the risk remains high, even if blood glucose levels are later brought under control.